National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.
The Affiliated Hospital, Jiangxi University of Chinese Medicine, Nanchang, China.
Drug Deliv. 2022 Dec;29(1):3432-3442. doi: 10.1080/10717544.2022.2149894.
Modifying nanocrystals with functional materials have been common strategy to enlarge the enhancing ability on oral absorption via nanocrystals; however, whether the functional materials have played their full enhancing ability in oral absorption is still unknown. In this study, we synthetized a novel chitosan-based copolymer (the copolymer of sodium dodecyl sulfate (SDS), chitosan (CS) and D-α-Tocopherol polyethylene glycol 1000 succinate, SDS-CS-TPGS), and modified nanocrystals with this copolymer, aiming to enhance the oral absorption of polymer andrographolide (ADR). In real-time distribution study, we found the distribution of ADR, SDS, CS and TPGS varies in gastrointestinal tract, while the distribution of ADR and SDS-CS-TPGS was similar, revealing the SDS-CS-TPGS could able to participate in the absorption process of andrographolide timely. To explore the oral absorption enhancing ability of SDS-CS-TPGS, we prepared a series of nanocrystals modified with different materials and explored their pharmacokinetic performances on SD rats. The results showed the nanocrystals modified with SDS-CS-TPGS (S-C-TANs) exhibited the highest bioavailability, which could enhance the AUC of ADR from 1.291 mg/Lh to 5.275 mg/Lh (enhanced for about 4.09-folds). The enhanced anti- inflammatory efficacy was also found on ICR mice by employing ear swelling rate, TNF-α, IL-1β and IL-6 and pharmacodynamic index. These results indicated that modified with synthesized copolymer containing different functional stabilizers is an efficient strategy to enlarge the enhancing ability on oral absorption of nanocrystals.
用功能材料修饰纳米晶体是提高纳米晶体口服吸收增强能力的常用策略;然而,功能材料在口服吸收中是否发挥了其全部增强能力仍不清楚。在这项研究中,我们合成了一种新型壳聚糖基共聚物(十二烷基硫酸钠(SDS)、壳聚糖(CS)和 D-α-生育酚聚乙二醇 1000 琥珀酸共聚物,SDS-CS-TPGS),并用该共聚物修饰纳米晶体,旨在提高聚合物穿心莲内酯(ADR)的口服吸收。在实时分布研究中,我们发现 ADR、SDS、CS 和 TPGS 在胃肠道中的分布不同,而 ADR 和 SDS-CS-TPGS 的分布相似,表明 SDS-CS-TPGS 能够及时参与穿心莲内酯的吸收过程。为了探讨 SDS-CS-TPGS 的口服吸收增强能力,我们制备了一系列用不同材料修饰的纳米晶体,并研究了它们在 SD 大鼠上的药代动力学性能。结果表明,用 SDS-CS-TPGS 修饰的纳米晶体(S-C-TANs)表现出最高的生物利用度,可将 ADR 的 AUC 从 1.291mg/Lh 提高到 5.275mg/Lh(增强约 4.09 倍)。通过采用耳肿胀率、TNF-α、IL-1β 和 IL-6 和药效学指数,在 ICR 小鼠中也发现了增强的抗炎功效。这些结果表明,用含有不同功能稳定剂的合成共聚物修饰纳米晶体是提高纳米晶体口服吸收增强能力的有效策略。